Paveena Pithuksurachai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Paveena Pithuksurachai has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Prachya Maneeprasopchoke
Division of Thyroid and Parathyroid Endocrine Surgery, Department of Otolaryngology‐Head and Neck Surgery, Massachusetts Eye and Ear Harvard Medical School Boston Massachusetts USA
4 shared publications - Aimpat Aungsusiripong
Department of Otorhinolaryngology, Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Thailand
2 shared publications - Amr H. Abdelhamid Ahmed
Division of Thyroid and Parathyroid Endocrine Surgery, Department of Otolaryngology‐Head and Neck Surgery, Massachusetts Eye and Ear Harvard Medical School Boston Massachusetts USA
2 shared publications - Angkoon Anuwong
Division of Minimally Invasive and Endocrine Surgery, Department of Surgery, Police General Hospital, Bangkok, Thailand
2 shared publications - Gregory William Randolph
Division of Thyroid and Parathyroid Endocrine Surgery, Department of Otolaryngology‐Head and Neck Surgery, Massachusetts Eye and Ear Harvard Medical School Boston Massachusetts USA
2 shared publications - Marika D. Russell
Division of Thyroid and Parathyroid Endocrine Surgery, Department of Otolaryngology‐Head and Neck Surgery, Massachusetts Eye and Ear Harvard Medical School Boston Massachusetts USA
2 shared publications
Latest Publications
- Open Access
- 18 September 2026
- Published by Wiley in The Laryngoscope
Visual Parathyroid Identification in Thyroidectomy: A Decision Curve Analysis of Gland Preservation
Objective: To evaluate the clinical utility and net benefit of intraoperative visual identification for parathyroid preservation during thyroidectomy using decision curve analysis (DCA). Methods: Suspected parathyroid tissues ( n = 50) were identified intraoperatively by junior staff and residents and photographed for independent consensus review by three expert otolaryngologists. Fine‐needle aspiration parathyroid hormone washout (electrochemiluminescence immunoassay; ≥ 100 pg/mL) served as the surrogate biochemical reference standard. Diagnostic performance was assessed using contingency tables, logistic regression, receiver operating characteristic analysis, and DCA. Results: Expert visual identification achieved 84.0% sensitivity, 44.0% specificity, and 64.0% accuracy. Positive predictive values were 60.0% for experts, 51.5% for junior staff, and 47.1% for residents ( p = 0.632). Logistic regression yielded odds ratios of 1.69 for experts ( p = 0.380) and 1.20 for junior staff ( p = 0.765); model AUC was 0.56. DCA showed greater net benefit than “Treat All” and “Treat None” strategies at a clinically relevant threshold probability of 27%. Conclusion: Visual identification demonstrates limited diagnostic accuracy that did not differ significantly across experience levels, although this comparison is constrained by differing assessment conditions. The low specificity underscores the need for objective adjunctive confirmation and supports evaluating biochemical and optical adjuncts in future prospective studies. Level of Evidence: 2.
- 18 September 2026
- Published by Wiley in The Laryngoscope
Open AccessVisual Parathyroid Identification in Thyroidectomy: A Decision Curve Analysis of Gland Preservation
Objective: To evaluate the clinical utility and net benefit of intraoperative visual identification for parathyroid preservation during thyroidectomy using decision curve analysis (DCA). Methods: Suspected parathyroid tissues ( n = 50) were identified intraoperatively by junior staff and residents and photographed for independent consensus review by three expert otolaryngologists. Fine‐needle aspiration parathyroid hormone washout (electrochemiluminescence immunoassay; ≥ 100 pg/mL) served as the surrogate biochemical reference standard. Diagnostic performance was assessed using contingency tables, logistic regression, receiver operating characteristic analysis, and DCA. Results: Expert visual identification achieved 84.0% sensitivity, 44.0% specificity, and 64.0% accuracy. Positive predictive values were 60.0% for experts, 51.5% for junior staff, and 47.1% for residents ( p = 0.632). Logistic regression yielded odds ratios of 1.69 for experts ( p = 0.380) and 1.20 for junior staff ( p = 0.765); model AUC was 0.56. DCA showed greater net benefit than “Treat All” and “Treat None” strategies at a clinically relevant threshold probability of 27%. Conclusion: Visual identification demonstrates limited diagnostic accuracy that did not differ significantly across experience levels, although this comparison is constrained by differing assessment conditions. The low specificity underscores the need for objective adjunctive confirmation and supports evaluating biochemical and optical adjuncts in future prospective studies. Level of Evidence: 2.
- Open Access
- 28 May 2026
- Published by Elsevier in Pain Management Nursing
- Vol. 27 (5) , e1035-e1041
Pain Outcomes and Predictors in Transoral Vestibular Thyroidectomy
- 28 May 2026
- Published by Elsevier in Pain Management Nursing
- Vol. 27 (5) , e1035-e1041
Open AccessPain Outcomes and Predictors in Transoral Vestibular Thyroidectomy
- Open Access
- 6 May 2026
- Published by Elsevier in Asian Journal of Surgery
Determinants of patient preference for TOETVA versus open thyroidectomy: Patient-reported outcome measures
- 6 May 2026
- Published by Elsevier in Asian Journal of Surgery
Open AccessDeterminants of patient preference for TOETVA versus open thyroidectomy: Patient-reported outcome measures
- 23 April 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (8) , 3648-3650
A Simple Technique for Probe‐Based NIRAF ‐Guided Parathyroid Identification in TOETVA
We describe a technique for probe-based near-infrared autofluorescence (NIRAF)-guided parathyroid identification during TOETVA. The probe is mounted on a suction cannula and introduced via the central port, allowing real-time confirmation of parathyroid tissue without device modification. This approach enables integration of NIRAF into remote-access thyroid surgery.
- 23 April 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (8) , 3648-3650
A Simple Technique for Probe‐Based NIRAF ‐Guided Parathyroid Identification in TOETVA
We describe a technique for probe-based near-infrared autofluorescence (NIRAF)-guided parathyroid identification during TOETVA. The probe is mounted on a suction cannula and introduced via the central port, allowing real-time confirmation of parathyroid tissue without device modification. This approach enables integration of NIRAF into remote-access thyroid surgery.
- 5 January 2026
- Published by Wiley in Head & Neck
- Vol. 48 (6) , 1473-1482
A Novel Connector for Intraoperative Nerve Monitoring Probes in Endoscopic Thyroidectomy: Comparative Efficacy and Preclinical Evaluation in a Porcine Model
Background: This study aimed to develop a connector that adapts standard endoscopic instruments into functional nerve stimulator probes. Methods: The connector underwent engineering validation in a laboratory and preclinical testing using a porcine model. A handheld standard stimulator probe served as the control. The experimental group consisted of a long monopolar probe and two connector‐adapted probes. Recurrent laryngeal nerve (RLN) and vagus nerves were stimulated to compare the efficacy and safety of the adapted probes with the standard probe. Results: The connector, when coupled to endoscopic instruments, did not show a statistically significant difference in electromyographic (EMG) amplitude at 1 mA stimulation compared with the standard probe. Safety analysis showed no significant hemodynamic effects. Conclusion: This proof‐of‐concept study demonstrates that the developed connector, when paired with endoscopic instruments, enables reliable nerve identification and preservation during endoscopic thyroid surgery, with favorable efficacy and safety profiles.
- 5 January 2026
- Published by Wiley in Head & Neck
- Vol. 48 (6) , 1473-1482
A Novel Connector for Intraoperative Nerve Monitoring Probes in Endoscopic Thyroidectomy: Comparative Efficacy and Preclinical Evaluation in a Porcine Model
Background: This study aimed to develop a connector that adapts standard endoscopic instruments into functional nerve stimulator probes. Methods: The connector underwent engineering validation in a laboratory and preclinical testing using a porcine model. A handheld standard stimulator probe served as the control. The experimental group consisted of a long monopolar probe and two connector‐adapted probes. Recurrent laryngeal nerve (RLN) and vagus nerves were stimulated to compare the efficacy and safety of the adapted probes with the standard probe. Results: The connector, when coupled to endoscopic instruments, did not show a statistically significant difference in electromyographic (EMG) amplitude at 1 mA stimulation compared with the standard probe. Safety analysis showed no significant hemodynamic effects. Conclusion: This proof‐of‐concept study demonstrates that the developed connector, when paired with endoscopic instruments, enables reliable nerve identification and preservation during endoscopic thyroid surgery, with favorable efficacy and safety profiles.
- Open Access
- 1 June 2021
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 14, 3959-3969
The Association Between Radioiodine Refractory in Papillary Thyroid Carcinoma, Sodium/Iodide Symporter Expression, and BRAFV600E Mutation
Objective: To study the association between radioiodine refractory papillary thyroid carcinoma, sodium/iodide symporter (NIS) expression, and the BRAFV600E mutation. Methods: A study was conducted on 30 radioiodine refractory papillary thyroid carcinoma patients and 30 radioiodine-avid papillary thyroid carcinoma patients. The expressions of sodium/iodide symporter and BRAFV600E mutated protein were determined by immunohistochemistry using formalin-fixed, paraffin-embedded tissue. Results: The mutated BRAFV600E protein was identified in 26 radioiodine refractory papillary thyroid carcinoma subjects (86.7%) and 22 radioiodine-avid papillary thyroid carcinoma subjects (73.3%), with no significant difference between the 2 groups (P = 0.3). Sodium/iodide symporter expression was detected in 4 of 30 cases (13.3%) from the radioiodine-avid papillary thyroid carcinoma group but was negative for all radioiodine refractory cases. There was no association between sodium/iodide symporter expression and radioiodine refractory papillary thyroid carcinoma (P = 0.11). Cases with positive NIS expression were likely negative for BRAFV600E mutation (3/4; P = 0.02). Conclusion: Papillary thyroid carcinomas with BRAFV600E mutation were more likely to be negative for NIS expression. BRAFV600E mutation and NIS expressions cannot be used to predict radioiodine sensitivity.
- 1 June 2021
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 14, 3959-3969
Open AccessThe Association Between Radioiodine Refractory in Papillary Thyroid Carcinoma, Sodium/Iodide Symporter Expression, and BRAFV600E Mutation
Objective: To study the association between radioiodine refractory papillary thyroid carcinoma, sodium/iodide symporter (NIS) expression, and the BRAFV600E mutation. Methods: A study was conducted on 30 radioiodine refractory papillary thyroid carcinoma patients and 30 radioiodine-avid papillary thyroid carcinoma patients. The expressions of sodium/iodide symporter and BRAFV600E mutated protein were determined by immunohistochemistry using formalin-fixed, paraffin-embedded tissue. Results: The mutated BRAFV600E protein was identified in 26 radioiodine refractory papillary thyroid carcinoma subjects (86.7%) and 22 radioiodine-avid papillary thyroid carcinoma subjects (73.3%), with no significant difference between the 2 groups (P = 0.3). Sodium/iodide symporter expression was detected in 4 of 30 cases (13.3%) from the radioiodine-avid papillary thyroid carcinoma group but was negative for all radioiodine refractory cases. There was no association between sodium/iodide symporter expression and radioiodine refractory papillary thyroid carcinoma (P = 0.11). Cases with positive NIS expression were likely negative for BRAFV600E mutation (3/4; P = 0.02). Conclusion: Papillary thyroid carcinomas with BRAFV600E mutation were more likely to be negative for NIS expression. BRAFV600E mutation and NIS expressions cannot be used to predict radioiodine sensitivity.